Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-05

Clinical Trial Update: A Study of N9 Chemotherapy in Children With Neuroblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 study evaluating N9 chemotherapy in children with neuroblastoma. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N9 chemotherapy (N9)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma, Pediatric Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING